2023
DOI: 10.1021/acsami.2c15327
|View full text |Cite
|
Sign up to set email alerts
|

Hollow CoP@N–Carbon Nanospheres: Heterostructure and Glucose-Enhanced Charge Separation for Sonodynamic/Starvation Therapy

Abstract: Sonodynamic therapy (SDT) can be described as ultrasonic (US) catalysis. Adequate charge separation is considered as effective means to promote reactive oxygen species (ROS). Here, hollow CoP@N–carbon@PEG (CPCs@PEG) nanospheres (∼60 nm) are prepared as sonosensitizers, showing greater ROS generation than pure CoP@PEG under US irradiation. Both 1O2 and ·O2 – are activation species that are determined by O2 and electrons. The great SDT performance of CPCs@PEG is ascribed to the heterostructure which promotes the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 37 publications
(49 reference statements)
0
1
0
Order By: Relevance
“…On the one hand, ST can reduce the internal glucose of tumors and reduce the energy source of tumor cells. CAT and CAT-like activity Au-rGO-ZnO@PVP, PMR, PEBVO@PEGNRS, Bac@ARS, SPNC, PB+Ce6@Hy, Ce6-MnO 2 -PVs, YHM, Cu 2 O-CNX@CeO 2 , CAT@HA-HMME NPs [51,53,54,156,157,158,159,160,161,162] Consumption of GSH AIMP [163] Catalytic CDT Mn 3 O 4 /OCN-PPIX@BSA, G-IrTe 2 [164,165] Suppress GSH generation BMP-BSO [166] Consumption of GSH, catalytic CDT UPFB, mZMD NCs, MO@FHO, AIPH@Cu-MOF [52,55,84,85] Consumption of GSH, catalytic ST CPCs@PEG [167] Reverse immunosuppression HABT-C@HA, MFC [168,169] Catalytic ST PPGE NCs [50] Consumption of GSH, catalytic CDT, catalytic ST MPG [170] pH-response DOX@PCN-224/Pt NPs [171] Carry oxygen Reverse immunosuppression TL@HPN(PAI/USI), DMXAAS [172,173] ICG-DOX NPs/PFH@SP94-Lip, SAFE [174,175] Autogeneration of oxygen Chl (MChl) [176] Reduce HIF-1𝛼 M@C [73] Reduce HIF-1𝛼 Relieve hypoxia P-BTO [71] IR780@INPS-CTX, IRP-NPs [177,178] Hypoxia-response ZTC, MCA, C-TiO 2 /TPZ@CM [77,179,180] Catalytic CDT Cu-MOF NPs [75] CAT activity hMVS [78] On the other hand, the produced H 2 O 2 can be used as the substrate of CDT and catalase to catalyze the formation of ROS and oxygen. [56]…”
Section: Tme and Tme-related Sdtmentioning
confidence: 99%
“…On the one hand, ST can reduce the internal glucose of tumors and reduce the energy source of tumor cells. CAT and CAT-like activity Au-rGO-ZnO@PVP, PMR, PEBVO@PEGNRS, Bac@ARS, SPNC, PB+Ce6@Hy, Ce6-MnO 2 -PVs, YHM, Cu 2 O-CNX@CeO 2 , CAT@HA-HMME NPs [51,53,54,156,157,158,159,160,161,162] Consumption of GSH AIMP [163] Catalytic CDT Mn 3 O 4 /OCN-PPIX@BSA, G-IrTe 2 [164,165] Suppress GSH generation BMP-BSO [166] Consumption of GSH, catalytic CDT UPFB, mZMD NCs, MO@FHO, AIPH@Cu-MOF [52,55,84,85] Consumption of GSH, catalytic ST CPCs@PEG [167] Reverse immunosuppression HABT-C@HA, MFC [168,169] Catalytic ST PPGE NCs [50] Consumption of GSH, catalytic CDT, catalytic ST MPG [170] pH-response DOX@PCN-224/Pt NPs [171] Carry oxygen Reverse immunosuppression TL@HPN(PAI/USI), DMXAAS [172,173] ICG-DOX NPs/PFH@SP94-Lip, SAFE [174,175] Autogeneration of oxygen Chl (MChl) [176] Reduce HIF-1𝛼 M@C [73] Reduce HIF-1𝛼 Relieve hypoxia P-BTO [71] IR780@INPS-CTX, IRP-NPs [177,178] Hypoxia-response ZTC, MCA, C-TiO 2 /TPZ@CM [77,179,180] Catalytic CDT Cu-MOF NPs [75] CAT activity hMVS [78] On the other hand, the produced H 2 O 2 can be used as the substrate of CDT and catalase to catalyze the formation of ROS and oxygen. [56]…”
Section: Tme and Tme-related Sdtmentioning
confidence: 99%